In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK have produced public the outcomes of a series of short-term and long-term research on the effects of cannabinoids amongst patients with multiple sclerosis. The previously performed studies involved the active participation of close to 600 individuals with advanced-stage multiple sclerosis. The participants had been divided in two distinctive groups: the first group received cannabinoid compounds in equal doses, whilst the second group received placebo medications over a period of 15 weeks. By the end of the experiment, the majority of patients who were administered cannabinoids skilled considerable symptomatic improvements, having much less muscular pain and getting confronted with milder muscular spasticity (less pronounced muscular spasm). As opposed to the group that received cannabinoid compounds more than the whole period of the study, the control group (sufferers who received placebo medicines) experienced no enhancements in their general problem. In order to confirm the relevancy of the findings and to discard any doubts regarding the efficiency of cannabis in ameliorating the signs and symptoms of multiple sclerosis, the study was later repeated. The ulterior study was carried out over a period of 12 months, and involved the participation of the same subjects. Nonetheless, this time the participants had been divided into 3 distinctive groups instead of two as in the case of the prior experiment. The first group received tablets of D9-tetrahydrocannabinol (THC) - the active element in cannabis, the second group received normal cannabis extracts, although the third group received placebo medicines. In the finish of the experiment, individuals had been meticulously evaluated and examined by a team of physiotherapists and neurologists. The most beneficial results had been obtained among the sufferers belonging to the initial study group, the majority of subjects who've received equal doses of THC experiencing considerable improvements in their symptoms. The patients within the second study group experienced slight enhancements in their symptoms, while the sufferers within the third group felt no changes in their condition. Regardless of the fact these research clearly suggest that cannabis is an efficient remedy for multiple sclerosis, medical scientists are not nonetheless convinced that cannabinoids can be successfully used inside the treatment of multiple sclerosis. Nonetheless, soon after performing additional studies on the matter and far more elaborate study, doctors may possibly take into account to introduce cannabinoid compounds within the remedy of multiple sclerosis inside the near long term.
- The Multiple Sclerosis-Reversing Breakthrough - Download Now
A scientific breakthrough technology for curing Multiple Sclerosis...
- My Story: One Woman's Journey With Multiple Sclerosis - Download Now
One MS sufferer shares her touching life story and remarkable "miracle cure" diet in this new ebook...
0 comments:
Post a Comment